186 related articles for article (PubMed ID: 10941935)
1. Sensitive enzyme-linked immunosorbent assays for the detection of bacterial superantigens and antibodies against them in human plasma.
Miwa K; Fukuyama M; Sakai R; Shimizu S; Ida N; Endo M; Igarashi H
Microbiol Immunol; 2000; 44(6):519-23. PubMed ID: 10941935
[TBL] [Abstract][Full Text] [Related]
2. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
3. Superantigens and pseudosuperantigens of gram-positive cocci.
Fleischer B; Gerlach D; Fuhrmann A; Schmidt KH
Med Microbiol Immunol; 1995 May; 184(1):1-8. PubMed ID: 8538573
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating superantigens in an intensive care unit population.
Azuma K; Koike K; Kobayashi T; Mochizuki T; Mashiko K; Yamamoto Y
Int J Infect Dis; 2004 Sep; 8(5):292-8. PubMed ID: 15325598
[TBL] [Abstract][Full Text] [Related]
5. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus.
Lee PK; Schlievert PM
Curr Top Microbiol Immunol; 1991; 174():1-19. PubMed ID: 1802616
[No Abstract] [Full Text] [Related]
7. Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1.
Hynes WL; Weeks CR; Iandolo JJ; Ferretti JJ
Infect Immun; 1987 Mar; 55(3):837-8. PubMed ID: 3546143
[TBL] [Abstract][Full Text] [Related]
8. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to Staphylococcus aureus Toxic Shock Syndrome Toxin-1 using a competitive agglutination inhibition assay.
Javid Khojasteh V; Rogan MT; Edwards-Jones V; Foster HA
Lett Appl Microbiol; 2003; 36(6):372-6. PubMed ID: 12753244
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils.
Hensler T; Köller M; Geoffroy C; Alouf JE; König W
Infect Immun; 1993 Mar; 61(3):1055-61. PubMed ID: 8381770
[TBL] [Abstract][Full Text] [Related]
11. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.
Müller-Alouf H; Proft T; Zollner TM; Gerlach D; Champagne E; Desreumaux P; Fitting C; Geoffroy-Fauvet C; Alouf JE; Cavaillon JM
Infect Immun; 2001 Jun; 69(6):4141-5. PubMed ID: 11349089
[TBL] [Abstract][Full Text] [Related]
12. Cytolysins augment superantigen penetration of stratified mucosa.
Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
[TBL] [Abstract][Full Text] [Related]
13. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
Smith RJ; Schlievert PM; Himelright IM; Baddour LM
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
[TBL] [Abstract][Full Text] [Related]
14. Rapid assay for detection of toxic shock syndrome toxin 1 from human sera.
Miwa K; Fukuyama M; Kunitomo T; Igarashi H
J Clin Microbiol; 1994 Feb; 32(2):539-42. PubMed ID: 8150970
[TBL] [Abstract][Full Text] [Related]
15. Molecular structure of staphylococcus and streptococcus superantigens.
Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of immunisation against diphtheria, pertussis and tetanus (DPT) in relation to sudden infant death syndrome.
Essery SD; Raza MW; Zorgani A; MacKenzie DA; James VS; Weir DM; Busuttil A; Hallam N; Blackwell C
FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):183-92. PubMed ID: 10443507
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two newly developed forms of an enzyme-linked immunosorbent assay for the detection of staphylococcal toxic shock syndrome toxin-1 (TSST-1).
Pickenhahn P; Lenz W; Schaal KP
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Dec; 267(2):206-16. PubMed ID: 3447385
[TBL] [Abstract][Full Text] [Related]
18. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
Leung DY; Meissner C; Fulton D; Schlievert PM
J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
[TBL] [Abstract][Full Text] [Related]
19. [Stimulation of the immune system by microbial "superantigens"].
Fleischer B
Immun Infekt; 1991 Feb; 19(1):8-11. PubMed ID: 2060968
[TBL] [Abstract][Full Text] [Related]
20. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
Morita A; Imada Y; Igarashi H; Yutsudo T
Microbiol Immunol; 1997; 41(11):895-900. PubMed ID: 9444333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
